FEDERALUnknownHealthcareHealthcareLow
Avalo Therapeutics, Inc.
bd_d66e1f71e63a639e · schema v1 · pii pii-v1
Full breach record for Avalo Therapeutics, Inc. →Avalo Therapeutics' Item 1C disclosure describes its Information Security Program, governance (ISWG, Audit Committee oversight), NIST CSF-based controls, third-party MSSP monitoring, vendor risk assessments, and annual employee security awareness training including phishing simulations. The filing explicitly states the company has not identified any material cybersecurity incident to date. No breach is disclosed.
Tracked as a single-filing incident — the only disclosure on record for this event so far.ConfirmedView incident
Source provenance
- Source URL
- https://www.sec.gov/Archives/edgar/data/1534120/000162828024013786/avtx-20231231.htm
DisclosureLens renders the full SEC/HHS filing inline below from the originating regulator’s public record (§4.5 fair report privilege).
- Filed at
- Mar 29, 2024
- Raw hash
- 956e240f5a35ab964dde76d267ca5b0bc5609449ce33a71ef45dec6a8bf4c4e4
Source filing
AI-assisted summary above. The structured extract on this page was generated from the document below. Inspect the source to verify or correct any field.
Reporting entity
- Name
- Avalo Therapeutics, Inc.norm: avalo therapeutics
Victim entity
- Name
- Avalo Therapeutics, Inc.norm: avalo therapeutics
- SEC CIK
- 1534120
- Industry
- Healthcarellm
Incident
- Discovered
- —
- Materiality determined
- —
- Notification sent
- —
- Affected individuals
- Not disclosed
- Data types
- —
- Attack vector
- Unknown
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.